Mr. Thompson, a patient undergoing chemotherapy, presents with anemia, neutropenia, and electrolyte imbalances. Which nursing intervention is the priority to address his current condition?

C) Start intravenous fluids to correct dehydration and electrolyte imbalances.

A) Administer a blood transfusion to correct anemia.

B) Initiate oxygen therapy to improve oxygen saturation.

C) Start intravenous fluids to correct dehydration and electrolyte imbalances.

D) Administer broad-spectrum antibiotics to prevent infection.

A patient undergoing chemotherapy presents with fatigue, shortness of breath, and peripheral neuropathy. Laboratory results show hemoglobin at 8.2 g/dL, WBC count of 3,000/mm³, creatinine at 1.5 mg/dL, sodium at 130 mEq/L, and potassium at 3.2 mEq/L. Which nursing intervention should be prioritized to address the most immediate risk to the patient's health?

C) Initiate broad-spectrum antibiotics to prevent infection

A) Administer oxygen therapy to improve oxygen saturation

B) Start intravenous fluids to correct dehydration and electrolyte imbalances

C) Initiate broad-spectrum antibiotics to prevent infection

D) Prepare for a blood transfusion to address anemia

A nurse is caring for Mr. Thompson, who has been diagnosed with a gram-negative bacterial infection and is currently neutropenic. Given his current presentation and history, which nursing intervention is the most critical to prioritize?

A) Initiating strict hand hygiene and infection control measures

B) Increasing the frequency of oxygen saturation monitoring

C) Administering antipyretics to manage his persistent fever

D) Encouraging oral fluid intake to prevent dehydration

A nurse is caring for Mr. Thompson, who has been diagnosed with a gram-negative bacterial infection and is experiencing respiratory distress. Despite being on supplemental oxygen, his saturation remains at 92%, and his fever persists at 101.2°F. Considering his neutropenic status and recent laboratory findings, what is the priority nursing action?

C) Collaborate with the healthcare provider to adjust the antibiotic regimen to target the identified gram-negative bacterium.

A) Increase the rate of supplemental oxygen to improve oxygen saturation levels.

B) Administer prescribed diuretics to manage fluid overload and prevent pulmonary complications.

C) Collaborate with the healthcare provider to adjust the antibiotic regimen to target the identified gram-negative bacterium.

D) Perform frequent chest auscultations to monitor for adventitious lung sounds.

A nurse is caring for Mr. Thompson, who has developed acute kidney injury (AKI) and decreased urine output following an infection and nephrotoxic medication use. Which nursing intervention is the most appropriate to prioritize in this situation?

B) Collaborate with the healthcare team to adjust nephrotoxic medications.

A) Increase the rate of intravenous fluids to improve urine output.

B) Collaborate with the healthcare team to adjust nephrotoxic medications.

C) Administer diuretics to promote kidney function and increase urine output.

D) Limit fluid intake to prevent potential pulmonary congestion.

A nurse is reviewing the plan of care for Mr. Thompson, who is experiencing acute kidney injury (AKI) secondary to nephrotoxic medications and infection. Which intervention should the nurse prioritize to protect Mr. Thompson's renal function while addressing his fluid status?

B) Administer prescribed sodium bicarbonate to prevent metabolic acidosis.

A) Increase the dosage of diuretics to enhance urine output.

B) Administer prescribed sodium bicarbonate to prevent metabolic acidosis.

C) Restrict fluid intake to prevent pulmonary congestion.

D) Initiate a continuous renal replacement therapy (CRRT) session.

A nurse is caring for Mr. Thompson, who has oliguria and mild pulmonary edema. Which intervention should the nurse prioritize to address his respiratory compromise without exacerbating renal function?

B) Administer a prescribed low-dose diuretic while monitoring renal function closely.

A) Increase the infusion rate of intravenous fluids to improve urine output.

B) Administer a prescribed low-dose diuretic while monitoring renal function closely.

C) Reduce supplemental oxygen to encourage spontaneous breathing efforts.

D) Encourage oral fluid intake to improve hydration status.

A nurse is caring for Mr. Thompson, who has a history of renal insufficiency and is now exhibiting signs of mild pulmonary edema. Given his current condition, which nursing intervention should be prioritized to manage his fluid status and prevent further complications?

B) Administer prescribed diuretics and monitor for respiratory improvement.

A) Increase his fluid intake to promote renal perfusion.

B) Administer prescribed diuretics and monitor for respiratory improvement.

C) Restrict dietary sodium to manage fluid retention.

D) Initiate oxygen therapy to maintain oxygen saturation above 95%.

A nurse is caring for Mr. Thompson, whose potassium level has increased to 5.8 mEq/L, indicating hyperkalemia. Considering his compromised renal function and the presence of premature ventricular contractions, which intervention should the nurse prioritize to address the hyperkalemia?

A) Administer a potassium-binding resin as prescribed.

B) Increase the patient's oral fluid intake to promote renal clearance.

C) Encourage high-potassium foods to stabilize his potassium level.

D) Withhold all medications that contain magnesium to avoid interactions.

Chemotherapie - Nursing Case Study

Pathophysiology

• Primary mechanism: Chemotherapy primarily targets rapidly dividing cells by interfering with DNA replication or mitosis, causing cancer cell death. This effect is achieved through agents like alkylating agents, which bind to DNA and prevent cell division.

• Secondary mechanism: Some chemotherapy drugs, like antimetabolites, mimic the building blocks of DNA or RNA, leading to faulty nucleic acid synthesis and subsequent cell death. These drugs disrupt the metabolism of cancer cells, inhibiting their growth.

• Key complication: The non-selective nature of chemotherapy affects normal rapidly dividing cells, such as those in the bone marrow, gastrointestinal tract, and hair follicles, leading to side effects like immunosuppression, mucositis, and alopecia.

Patient Profile

Demographics:

62-year-old male, retired electrician

History:

• Key past medical history: Stage II colorectal cancer, hypertension, type 2 diabetes

• Current medications: Capecitabine, lisinopril, metformin, ondansetron as needed

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased fatigue and shortness of breath

• Key symptoms: Nausea, diarrhea, mild chest pain, peripheral neuropathy in hands and feet

• Vital signs: Temperature 100.4°F, blood pressure 150/95 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, oxygen saturation 90% on room air

Section 1

As the nursing team began the initial assessment, it was evident that the patient, Mr. Thompson, was experiencing significant distress from his chemotherapy regimen. His increased fatigue and shortness of breath raised concerns about potential anemia and pulmonary complications. Upon auscultation, diminished breath sounds were noted bilaterally, with crackles present at the lung bases, suggesting possible fluid overload or an early sign of infection. The mild chest pain reported by Mr. Thompson required further evaluation to rule out cardiac ischemia, especially considering his history of hypertension and poorly controlled diabetes. The peripheral neuropathy in his hands and feet, a common side effect of chemotherapy, was contributing to his overall discomfort and functional limitations.

Laboratory investigations revealed a hemoglobin level of 8.2 g/dL, indicating anemia, likely exacerbated by the myelosuppressive effects of chemotherapy. His white blood cell count was 3,000/mm³, suggesting neutropenia, which increased his risk for infections—a concern given his fever of 100.4°F. Additionally, his kidney function tests showed a slight elevation in creatinine at 1.5 mg/dL, possibly a result of dehydration from ongoing diarrhea and inadequate fluid intake. Electrolyte imbalances were also noted, with hyponatremia (sodium 130 mEq/L) and hypokalemia (potassium 3.2 mEq/L), which could contribute to his symptoms of fatigue and weakness.

The clinical team initiated several interventions to address these findings. Mr. Thompson was started on intravenous fluids to correct his dehydration and electrolyte imbalances. A blood transfusion was considered to manage his anemia, and broad-spectrum antibiotics were initiated as a precautionary measure against potential infection due to neutropenia. Oxygen therapy was administered to improve his oxygen saturation levels. The team planned to closely monitor his cardiac status and electrolyte levels, adjusting treatment as necessary. This comprehensive approach aimed to stabilize Mr. Thompson's condition, address the immediate complications, and prevent further deterioration, while also considering future adjustments to his chemotherapy plan to mitigate these adverse effects.

Section 2

As the clinical team continued to monitor Mr. Thompson, a series of new diagnostic results provided further insights into his condition. The repeat chest X-ray showed bilateral infiltrates more pronounced at the lung bases, corroborating the suspicion of fluid overload or an evolving pulmonary infection. Despite the initiation of antibiotics, Mr. Thompson's fever persisted, now climbing to 101.2°F, suggesting a potential resistant or atypical infection. His oxygen saturation, while improved with supplemental oxygen, remained marginal at 92%, and his respiratory rate was noted to be slightly increased at 24 breaths per minute, indicating ongoing respiratory distress.

Laboratory results from blood cultures revealed the presence of a gram-negative bacterium, necessitating a change in antibiotic regimen to better target the identified pathogen. The decision was made to escalate to a more potent antibiotic, considering his neutropenic status and the increased risk of sepsis. Additionally, his complete blood count showed a further drop in white blood cell count to 2,500/mm³, exacerbating concerns about his compromised immune status.

In response to these developments, the nursing team prioritized interventions to mitigate the new complications. Continued intravenous fluid administration was carefully balanced with diuretics to manage fluid overload while avoiding further renal compromise. Cardiac enzymes remained within normal limits, ruling out ischemic causes for his chest pain, but continuous cardiac monitoring was maintained due to his history and ongoing symptoms. The clinical team arranged for a consultation with an infectious disease specialist to ensure comprehensive management of Mr. Thompson's infection. This proactive approach aimed to address the immediate life-threatening risks while planning for the potential need to adjust his chemotherapy regimen to reduce future complications.

Section 3

As the clinical team continued to observe Mr. Thompson, a new complication emerged. Despite the adjusted antibiotic regimen, his condition took a turn with the development of acute kidney injury (AKI), likely secondary to both the infection and the nephrotoxic potential of his medications. Lab results indicated a rising creatinine level, now at 2.1 mg/dL, up from his baseline of 0.9 mg/dL, and a blood urea nitrogen (BUN) of 35 mg/dL. Urine output had noticeably decreased to less than 400 mL over the previous 24 hours, prompting the nursing team to re-evaluate his fluid management strategy and medication dosages.

In response to these findings, the team collaborated with the nephrology department to assess the severity of Mr. Thompson's renal compromise. A revised plan focused on optimizing his hydration status without exacerbating pulmonary congestion. Adjustments were made to his diuretic therapy, and nephrotoxic medications were reviewed to minimize further renal insult. A decision was made to initiate renal protective measures, including the administration of sodium bicarbonate, to mitigate the risk of metabolic acidosis.

Meanwhile, Mr. Thompson's respiratory status demonstrated marginal improvement with supplemental oxygen, but his respiratory rate remained elevated at 22 breaths per minute, and his oxygen saturation fluctuated around 93%. The priority was to maintain adequate oxygenation while carefully monitoring for signs of respiratory fatigue. The interdisciplinary team, including the infectious disease and nephrology specialists, coordinated a thorough review of Mr. Thompson's chemotherapy protocol. The goal was to strike a balance between effectively managing his malignancy and minimizing the risk of further complications, given his current immunocompromised and renal status. This comprehensive approach aimed to stabilize Mr. Thompson's condition while paving the way for a more tailored long-term management plan.

Section 4

As Mr. Thompson's treatment plan evolved, further developments in his condition required a nuanced clinical approach. The nephrology team monitored his renal function closely, noting that while his creatinine level plateaued at 2.1 mg/dL, his blood urea nitrogen (BUN) increased slightly to 38 mg/dL. This stabilization was cautiously optimistic, suggesting that the adjustments in medication and hydration strategy might be preventing further renal damage. However, his urine output remained low at 350 mL over the next 24 hours, indicating ongoing oliguria. The nursing staff was vigilant in assessing for signs of fluid overload, given the delicate balance needed to manage his renal and pulmonary statuses.

Simultaneously, Mr. Thompson's respiratory status presented a new complication. Despite maintaining a stable oxygen saturation of 92% on 2 liters of supplemental oxygen, he began to exhibit mild exertional dyspnea and developed a subtle bilateral wheeze upon auscultation. A repeat chest X-ray revealed mild pulmonary edema, likely a consequence of the fluid management strategy in the context of compromised renal clearance. The team convened to reassess his fluid and diuretic regimen, aiming to alleviate the pulmonary congestion while avoiding further renal insult. This required a careful titration of his diuretics and consideration of potential non-diuretic options to optimize his respiratory function without jeopardizing his renal recovery.

In response to these challenges, the interdisciplinary team prioritized the refinement of his chemotherapy protocol. Given the interplay between his treatment, renal function, and respiratory status, any modification had to be meticulously considered. The goal was to maintain oncological control while minimizing systemic toxicity. Mr. Thompson's case underscored the complexity of managing cancer patients with multi-organ involvement, necessitating a dynamic and responsive treatment plan. The team remained committed to monitoring his progress with frequent reassessments, ready to adapt the therapeutic strategies as his condition evolved.

Section 5

As Mr. Thompson's condition continued to evolve, the team encountered a new complication: his laboratory results indicated a worsening electrolyte imbalance. The latest blood work revealed that his potassium level had increased to 5.8 mEq/L, up from the previous 4.5 mEq/L. This hyperkalemia posed a significant risk, particularly given his compromised renal function and the potential for cardiac arrhythmias. Concurrently, his magnesium level had dropped to 1.4 mg/dL, adding to the complexity of his metabolic state. The nursing staff conducted a thorough cardiac assessment, noting the presence of occasional premature ventricular contractions on the telemetry monitor, which necessitated immediate attention to his electrolyte status.

In response to these findings, the interdisciplinary team swiftly convened to discuss the management strategy. The nephrology team recommended cautious administration of a potassium-binding resin to address the hyperkalemia, while also adjusting his fluid regimen to enhance renal clearance without exacerbating his pulmonary edema. Additionally, an intravenous magnesium supplement was initiated to correct the hypomagnesemia. The oncology team carefully reviewed his chemotherapy protocol, considering potential dose adjustments to mitigate further renal and electrolyte disturbances. The overarching goal was to stabilize his metabolic derangements while maintaining effective cancer treatment.

Throughout these interventions, the nursing staff remained vigilant, closely monitoring Mr. Thompson's vital signs and cardiac rhythm for any signs of deterioration. His blood pressure was stable at 128/76 mmHg, and his heart rate was consistent at 88 beats per minute, providing some reassurance that the immediate threat of cardiac complications was being managed. The team recognized the need for ongoing collaboration and frequent reassessments, understanding that Mr. Thompson's journey was far from over. As they navigated these challenges, they prepared for the possibility of further complications, ready to adapt their approach as his condition demanded.